BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6934374)

  • 1. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia.
    Greaves MF; Lister TA
    N Engl J Med; 1981 Jan; 304(2):119-20. PubMed ID: 6934374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic heterogeneity of acute lymphoblastic leukemia in children detected with xenogeneic antisera].
    Baryshnikov AIu; Tupitsin NN; Morozova LF; Tumian BG; Kadagidze ZG
    Ter Arkh; 1983; 55(11):81-6. PubMed ID: 6581572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute lymphocytic leukemia--immunological classification and prognosis].
    Chen P; Ho C; Hwang T; Ogasawara M; Kikuchi K
    Rinsho Ketsueki; 1982 Oct; 23(10):1555-60. PubMed ID: 6961243
    [No Abstract]   [Full Text] [Related]  

  • 4. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical investigation of two cases with acute lymphoblastic leukemia (FAB L2) showing monoclonal antigens associated with myelomonocyte].
    Nonoyama S; Minakuti J; Takase K; Takagi S; Okawa H; Yata J; Dan K
    Rinsho Ketsueki; 1986 Jun; 27(6):860-5. PubMed ID: 3463805
    [No Abstract]   [Full Text] [Related]  

  • 6. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte surface markers profile in acute lymphoblastic leukaemia.
    Mehta MM; Contractor NM; Gopal R; Advani SH; Thiel E; Thierfelder S; Bhatia HM
    Indian J Med Res; 1987 Sep; 86():329-34. PubMed ID: 3323042
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Baccarani M; Gobbi M; Tura S
    N Engl J Med; 1980 Jan; 302(2):123. PubMed ID: 6965316
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.
    Sobol RE; Mick R; Royston I; Davey FR; Ellison RR; Newman R; Cuttner J; Griffin JD; Collins H; Nelson DA
    N Engl J Med; 1987 Apr; 316(18):1111-7. PubMed ID: 3494942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.
    Cohen E; Singal DP; Khurana U; Gregory SG; Cox C; Sinks L; Henderson E; Fitzpatrick JE; Higby D
    Prog Clin Biol Res; 1977; 16():65-70. PubMed ID: 269457
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell surface markers in acute lymphoblastic leukemia.
    Humphrey GB; Blackstock R; Filler J
    Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute lymphoblastic leukemia in adults. Treatment results and prognosis].
    Johnsen HE; Bergmann OJ; Bastrup-Madsen P
    Ugeskr Laeger; 1987 Dec; 149(51):3460-4. PubMed ID: 3481142
    [No Abstract]   [Full Text] [Related]  

  • 13. Subset derivation of T-cell acute lymphoblastic leukemia in man.
    Reinherz EL; Nadler LM; Sallan SE; Schlossman SF
    J Clin Invest; 1979 Aug; 64(2):392-7. PubMed ID: 313405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic phenotypes of acute lymphoblastic leukemias and their clinico-biological correlations].
    San Miguel JF; González M; Caballero MD; Moro MJ; Prieto M; Moraleda JM; Tamagnini G; López Borrasca A
    Sangre (Barc); 1984; 29(5):849-60. PubMed ID: 6596755
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Bitran JD
    N Engl J Med; 1978 Dec; 299(23):1317. PubMed ID: 309555
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors and treatment response in acute lymphoblastic leukemia of children and adults treated with a non aggressive combination chemotherapy.
    Rizzo SC; Balduini CL; Invernizzi R; Ricevuti G; Fontana G; Ascari E
    Haematologica; 1980 Feb; 65(1):70-81. PubMed ID: 6768654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surface marker study of the peripheral blood blast cells and lymphocytes in acute leukemia using a rosette formation method].
    Loginskiĭ VE; Korotkiĭ VV; Kotsaĭ BR
    Lab Delo; 1978; (12):729-32. PubMed ID: 82668
    [No Abstract]   [Full Text] [Related]  

  • 18. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
    Brouet JC; Toben HR; Chevalier A; Seligmann M
    Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 20. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J; Rodziewicz B
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.